Jaswinder Singh Khera
Directeur Général chez WEP Clinical
Profil
Jaswinder Singh Khera has worked as a Managing Director at WEP Clinical and as a Director at WEP Group Holdings Ltd.
Postes actifs de Jaswinder Singh Khera
Sociétés | Poste | Début |
---|---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Directeur/Membre du Conseil | 19/12/2017 |
WEP Clinical
WEP Clinical Pharmaceuticals: MajorHealth Technology WEP Clinical is a specialist services company founded in 2008 that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available. The private company is based in Morrisville, NC, and has offices located in the UK, Switzerland, and Ireland. The company possesses all the necessary licenses allowing them to meet drug access and distribution needs across all regions worldwide. The company also provides pharmacovigilance (PV) services and drug commercialization services to help pharmaceutical companies successfully commercialize products in different countries where the product has yet to be registered. The CEO of the company is Jaswinder Singh Khera. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Distribution Services |
WEP Clinical
WEP Clinical Pharmaceuticals: MajorHealth Technology WEP Clinical is a specialist services company founded in 2008 that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available. The private company is based in Morrisville, NC, and has offices located in the UK, Switzerland, and Ireland. The company possesses all the necessary licenses allowing them to meet drug access and distribution needs across all regions worldwide. The company also provides pharmacovigilance (PV) services and drug commercialization services to help pharmaceutical companies successfully commercialize products in different countries where the product has yet to be registered. The CEO of the company is Jaswinder Singh Khera. | Health Technology |